Filed with the SEC on · Summarized by InvestorsBot
Timothy Schmid, Johnson & Johnson’s EVP and worldwide chair of MedTech, sold 33,597 shares in two open-market transactions on September 2 at $274.74 per share. The sales were valued at approximately $9.23 million, and he reported owning 25,447 shares after the transactions.
Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.
Subscribe freeJ&J EVP Jennifer Taubert sells $4.0M in stock
Form 4 · Insider Trade · August 18, 2026
J&J CEO Joaquin Duato sells approximately $32.2M in stock
Form 4 · Insider Trade · August 14, 2026
J&J CEO Joaquin Duato sells approximately $12.5M in stock
Form 4 · Insider Trade · August 7, 2026
J&J Chief Legal Officer sells $4.1M in stock
Form 4 · Insider Trade · August 7, 2026
J&J names Tom Cavanaugh to lead Innovative Medicine as Jennifer Taubert retires
8-K · August 4, 2026
J&J completes Firefly acquisition and announces $2.58 billion Sail option
8-K · July 29, 2026